 |
|
recombinant platelet factor 4
A recombinant form of the endogenous chemokine platelet factor 4 with potential antiangiogenesis and antineoplastic activities. As a heparin-binding tetramer, recombinant platelet factor 4 inhibits growth factor-stimulated endothelial cell proliferation, migration, and angiogenesis; it has been shown that this agent inhibits fibroblast growth factor 2 (FGF2) angiogenic activity downstream from the FGF2 receptor. Its activity is antagonized by heparin. Recombinant platelet factor 4 may also directly inhibit the proliferation of some tumor cell types. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | CXC-chemokine PF-4
CXCL4
platelet factor 4
recombinant human platelet factor 4 | | | | Acronyms: | | rhPF4
rPF4
rPF4 | | |
| Previous: | recombinant MAGE-3.1 antigen, recombinant MAGE-A3 antigen-specific cancer immunotherapeutic GSK1203486A, recombinant modified vaccinia Ankara-5T4 vaccine, recombinant nematode anticoagulant protein c2, recombinant parathyroid hormone | | Next: | recombinant soluble human CD4 protein, recombinant thyroid-stimulating hormone, recombinant thyrotropin alfa, recombinant tissue plasminogen activator, recombinant TNF-related apoptosis-inducing ligand |
|
|
